{"id":1227949,"date":[{"year":1999,"month":12,"day":3}],"page":"2","source":"本报","region":"","masthead":"综合新闻","special_issue":"","column":"","genre":"","count":"168","ytitle":"","mtitle":"冠生园进军生物医药新高地","ftitle":"","authors":["郑蔚","吴兰放"],"text":[{"type":"paragraph","text":"本报讯(记者郑蔚通讯员吴兰放)　只有50名员工的上海冠生园协和氨基酸有限公司，昨天正式建成投产，其产品不仅填补了国内空白、替代进口，90%的产品还将销往美国和欧洲。明年，该公司的生产规模将达到300吨，销售额将达到20亿日元，约合1.5亿元人民币。这是上海建设现代生物医药新高地的重点项目之一。"}]}